BRPI0919810A8 - Compostos heterocíclicos contendo nitrogênio, sua preparação e seu uso como medicamentos antibacterianos - Google Patents
Compostos heterocíclicos contendo nitrogênio, sua preparação e seu uso como medicamentos antibacterianosInfo
- Publication number
- BRPI0919810A8 BRPI0919810A8 BRPI0919810A BRPI0919810A BRPI0919810A8 BR PI0919810 A8 BRPI0919810 A8 BR PI0919810A8 BR PI0919810 A BRPI0919810 A BR PI0919810A BR PI0919810 A BRPI0919810 A BR PI0919810A BR PI0919810 A8 BRPI0919810 A8 BR PI0919810A8
- Authority
- BR
- Brazil
- Prior art keywords
- nitrogen
- preparation
- equal
- antibacterial drugs
- heterocyclic compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/18—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
COMPOSTOS HETEROCÍCLICOS CONTENDO NITROGÊNIO, SUA PREPARAÇÃO E SEU USO COMO MEDICAMENTOS ANTIBACTERIANOS. A invenção relaciona-se a compostos heterocíclicos contendo nitrogênio de fórmula geral (1) em que: R1 representa um radical (CH2)n-NH2, n sendo igual a 1 ou 2; R2 representa um átomo de hidrogênio; R3 e R4 formam juntos um heterociclo contendo nitrogênio com aromaticidade com 5 ápices, contendo 1, 2 ou 3 átomos de nitrogênio, substituídos nesse átomo de nitrogênio ou em um desses átomos de nitrogênio por um grupo (CH2)m-(C{O))p-Rs, m sendo igual a O, 1, 2 ou 3, p sendo igual a O ou 1 e Rs representando um grupo hidróxi, em que p é igual a 1, ou um amino, (C1-C6)alquila de grupo di-(C1- C6)alquilamino ou um heterociclo contendo nitrogênio com aromaticidade com 5 ou 6 ápices contendo 1 ou 2 átomos de nitrogênio e, se necessário, um átomo de oxigênio ou enxofre; compreende-se que quando o subgrupo (C(O))p-Rs forma um grupo carbóxi, amino, (C1-C6)alquila ou di(C1-C6) lquilamino, m é diferente de O ou 1; na forma livre ou como zwitterions e sais com bases e ácidos minerais ou orgânicos farmaceuticamente aceitáveis, a sua preparação e a seu uso como medicamentos antibacterianos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0805472A FR2936798B1 (fr) | 2008-10-03 | 2008-10-03 | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens. |
PCT/IB2009/006433 WO2010038115A1 (fr) | 2008-10-03 | 2009-08-03 | Nouveaux composes heterocycliques azotes, leur préparation et leur utilisation comme médicaments antibactériens |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0919810A2 BRPI0919810A2 (pt) | 2017-10-31 |
BRPI0919810A8 true BRPI0919810A8 (pt) | 2017-12-12 |
Family
ID=40548019
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0919810A BRPI0919810A8 (pt) | 2008-10-03 | 2009-08-03 | Compostos heterocíclicos contendo nitrogênio, sua preparação e seu uso como medicamentos antibacterianos |
Country Status (18)
Country | Link |
---|---|
US (1) | US8067435B2 (pt) |
EP (2) | EP2344499A1 (pt) |
JP (1) | JP5555240B2 (pt) |
KR (1) | KR20110067137A (pt) |
CN (1) | CN102203094B (pt) |
AU (1) | AU2009299511A1 (pt) |
BR (1) | BRPI0919810A8 (pt) |
CA (1) | CA2739503A1 (pt) |
CL (1) | CL2011000729A1 (pt) |
CO (1) | CO6361957A2 (pt) |
EA (1) | EA021799B1 (pt) |
EC (1) | ECSP11010946A (pt) |
FR (1) | FR2936798B1 (pt) |
IL (1) | IL212059A0 (pt) |
MX (1) | MX2011003573A (pt) |
PE (1) | PE20110845A1 (pt) |
WO (1) | WO2010038115A1 (pt) |
ZA (1) | ZA201102429B (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8772490B2 (en) | 2010-12-22 | 2014-07-08 | Meiji Seika Pharma Co., Ltd. | Optically active diazabicyclooctane derivatives and process for preparing the same |
EP2872510B1 (en) | 2011-08-30 | 2016-11-23 | Wockhardt Limited | 1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections |
BR112014003476A2 (pt) * | 2011-09-13 | 2017-03-01 | Wockhardt Ltd | compostos contendo nitrogênio e seu uso |
SG11201406120SA (en) * | 2012-03-30 | 2014-10-30 | Cubist Pharm Inc | ISOXAZOLE β-LACTAMASE INHIBITORS |
AR090539A1 (es) * | 2012-04-02 | 2014-11-19 | Astrazeneca Ab | COMPUESTOS INHIBIDORES DE b LACTAMASA |
PL2857401T3 (pl) * | 2012-05-30 | 2020-02-28 | Meiji Seika Pharma Co., Ltd. | NOWY INHIBITOR ß–LAKTAMAZY I SPOSÓB JEGO WYTWARZANIA |
BR112015003592B1 (pt) * | 2012-08-25 | 2020-04-14 | Wockhardt Ltd | derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas |
TWI644908B (zh) | 2013-09-24 | 2018-12-21 | 明治製菓藥業股份有限公司 | 二氮雜二環辛烷衍生物之製法及其中間體 |
EP3067355B1 (en) | 2013-10-08 | 2020-12-16 | Meiji Seika Pharma Co., Ltd. | Crystals of diazabicyclooctane derivative and production method for crystals of diazabicyclooctane derivative |
IN2013MU03216A (pt) * | 2013-10-11 | 2015-07-03 | Wockhardt Ltd | |
KR102542392B1 (ko) | 2014-11-17 | 2023-06-09 | 엔타시스 테라퓨틱스 리미티드 | 내성 박테리아 감염의 치료를 위한 배합물 치료제 |
JP6779787B2 (ja) | 2014-12-05 | 2020-11-04 | Meiji Seikaファルマ株式会社 | ジアザビシクロオクタン誘導体の結晶及び安定な凍結乾燥製剤の製造法 |
EP3075733A1 (en) * | 2015-03-31 | 2016-10-05 | Mutabilis | Novel heterocyclic compounds and their use in preventing or treating bacterial infections |
CA2980085A1 (en) * | 2015-03-31 | 2016-10-06 | Mutabilis | Novel heterocyclic compounds and their use in preventing or treating bacterial infections |
TW201639854A (zh) * | 2015-04-03 | 2016-11-16 | 木塔比利斯公司 | 雜環化合物及其用於預防或治療細菌感染的用途 |
US9951072B2 (en) | 2015-10-02 | 2018-04-24 | Legochem Biosciences, Inc. | Compositions and methods for inhibiting beta-lactamase |
KR102667828B1 (ko) | 2016-09-16 | 2024-05-20 | 엔타시스 테라퓨틱스 리미티드 | 베타-락타마제 억제제 화합물 |
MX2019013291A (es) | 2017-05-08 | 2020-01-15 | Entasis Therapeutics Inc | Compuestos y metodos para tratar infecciones bacterianas. |
EP3604315A1 (en) * | 2018-07-30 | 2020-02-05 | Mutabilis | Heterocyclic compounds and their use in preventing or treating bacterial infections |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0100051A3 (en) * | 1997-09-15 | 2002-08-28 | Procter & Gamble | Antimicrobial quinolones, their compositions and uses |
US6387928B1 (en) * | 1997-09-15 | 2002-05-14 | The Procter & Gamble Co. | Antimicrobial quinolones, their compositions and uses |
FR2812635B1 (fr) | 2000-08-01 | 2002-10-11 | Aventis Pharma Sa | Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens |
WO2002048138A1 (en) * | 2000-12-14 | 2002-06-20 | The Procter & Gamble Company | Antimicrobial quinolones |
PL363301A1 (en) * | 2000-12-14 | 2004-11-15 | The Procter & Gamble Company | Antimicrobial 2-pyridones, their compositions and uses |
FR2825705B1 (fr) * | 2001-06-08 | 2005-05-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens |
FR2833596B1 (fr) * | 2001-12-14 | 2005-02-18 | Aventis Pharma Sa | Procede de preparation de derives d'echinocandine |
FR2835186B1 (fr) * | 2002-01-28 | 2006-10-20 | Aventis Pharma Sa | Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases |
US6900224B2 (en) * | 2002-07-31 | 2005-05-31 | The Procter & Gamble Company | Antimicrobial quinolones, their compositions and uses |
FR2844273B1 (fr) | 2002-09-05 | 2008-04-04 | Aventis Pharma Sa | Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens. |
FR2844270B1 (fr) * | 2002-09-11 | 2006-05-19 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leur procede et intermediaires de preparation et les compositions qui les contiennent |
FR2844268B1 (fr) * | 2002-09-11 | 2004-10-22 | Aventis Pharma Sa | Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent |
FR2848210B1 (fr) * | 2002-12-06 | 2007-10-19 | Aventis Pharma Sa | Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases |
US7439253B2 (en) * | 2002-12-06 | 2008-10-21 | Novexel | Heterocyclic compounds, their preparation and their use as medicaments, in particular as antibacterials and beta-lactamase inhibitors |
US7232833B2 (en) * | 2003-03-28 | 2007-06-19 | Novexel | 4-substituted quinoline derivatives, method and intermediates for their preparation and pharmaceutical compositions containing them |
US7449481B2 (en) * | 2004-04-13 | 2008-11-11 | Cephalon, Inc. | Thio-substituted biaryl-methanesulfinyl derivatives |
FR2914923B1 (fr) * | 2007-04-12 | 2013-06-14 | Novexel | Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens. |
FR2937034B1 (fr) * | 2008-10-10 | 2012-11-23 | Novexel | Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens |
-
2008
- 2008-10-03 FR FR0805472A patent/FR2936798B1/fr not_active Expired - Fee Related
-
2009
- 2009-08-03 EP EP09786093A patent/EP2344499A1/fr not_active Withdrawn
- 2009-08-03 MX MX2011003573A patent/MX2011003573A/es active IP Right Grant
- 2009-08-03 KR KR1020117009615A patent/KR20110067137A/ko not_active Application Discontinuation
- 2009-08-03 CN CN200980141781.3A patent/CN102203094B/zh not_active Expired - Fee Related
- 2009-08-03 WO PCT/IB2009/006433 patent/WO2010038115A1/fr active Application Filing
- 2009-08-03 PE PE2011000827A patent/PE20110845A1/es not_active Application Discontinuation
- 2009-08-03 BR BRPI0919810A patent/BRPI0919810A8/pt not_active IP Right Cessation
- 2009-08-03 EA EA201170522A patent/EA021799B1/ru not_active IP Right Cessation
- 2009-08-03 AU AU2009299511A patent/AU2009299511A1/en not_active Abandoned
- 2009-08-03 EP EP14188601.0A patent/EP2845855A1/fr not_active Withdrawn
- 2009-08-03 CA CA2739503A patent/CA2739503A1/fr not_active Abandoned
- 2009-08-03 JP JP2011529643A patent/JP5555240B2/ja not_active Expired - Fee Related
- 2009-08-05 US US12/536,096 patent/US8067435B2/en not_active Expired - Fee Related
-
2011
- 2011-03-30 ZA ZA2011/02429A patent/ZA201102429B/en unknown
- 2011-03-31 IL IL212059A patent/IL212059A0/en unknown
- 2011-04-01 CL CL2011000729A patent/CL2011000729A1/es unknown
- 2011-04-01 CO CO11040684A patent/CO6361957A2/es active IP Right Grant
- 2011-04-01 EC EC2011010946A patent/ECSP11010946A/es unknown
Also Published As
Publication number | Publication date |
---|---|
IL212059A0 (en) | 2011-06-30 |
ZA201102429B (en) | 2012-05-30 |
JP5555240B2 (ja) | 2014-07-23 |
FR2936798A1 (fr) | 2010-04-09 |
EA201170522A1 (ru) | 2011-12-30 |
EP2344499A1 (fr) | 2011-07-20 |
CA2739503A1 (fr) | 2010-04-08 |
CO6361957A2 (es) | 2012-01-20 |
CL2011000729A1 (es) | 2012-07-06 |
AU2009299511A1 (en) | 2010-04-08 |
JP2012504593A (ja) | 2012-02-23 |
US20100087648A1 (en) | 2010-04-08 |
US8067435B2 (en) | 2011-11-29 |
KR20110067137A (ko) | 2011-06-21 |
ECSP11010946A (es) | 2011-05-31 |
WO2010038115A1 (fr) | 2010-04-08 |
PE20110845A1 (es) | 2011-11-17 |
EP2845855A1 (fr) | 2015-03-11 |
CN102203094A (zh) | 2011-09-28 |
MX2011003573A (es) | 2011-08-12 |
BRPI0919810A2 (pt) | 2017-10-31 |
CN102203094B (zh) | 2014-04-02 |
EA021799B1 (ru) | 2015-09-30 |
FR2936798B1 (fr) | 2012-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919810A8 (pt) | Compostos heterocíclicos contendo nitrogênio, sua preparação e seu uso como medicamentos antibacterianos | |
MX2011011485A (es) | Sulfonamidas nematocidas. | |
HN2009000502A (es) | DERIVADOS DE 2- ARIL-6-FENIL-IMIDAZO[ 1,2-a] PIRIDINAS SU PREPARACION Y SU APLICACION EN TERAPEUTICA | |
MX343596B (es) | Sulfonamidas nematocidas. | |
BRPI1008498B8 (pt) | compostos de piridazinona úteis como inibidores da fosfodiesterase 10a, composição farmacêutica, e, uso de um composto | |
AR067757A1 (es) | Derivados de imidazo[4,5-c]piridin-2-ona, composiciones farmaceuticas que los contienen, procedimiento para su preparacion y uso de los mismos como agentes antivirales. | |
BRPI0921701B8 (pt) | Cefarosporina tendo um grupo catecol, seu uso e composição farmacêutica que a compreende | |
BRPI1013821A8 (pt) | piridinas substituídas como antagonistas de ccr3. | |
BR112015009777A2 (pt) | derivado de amina ou sal do mesmo | |
CO6640247A2 (es) | Compuesto[5.6]heterociclico o una sal farmacológicamente aceptable del mismo útil para la prevención de enfermedades asociadas con el metabolismo óseo | |
BR112014024279A8 (pt) | Compostos heterobicíclicos como inibidores de beta-lactamase, composição farmacêutica, uso de um composto | |
BR112015015275A8 (pt) | composto heterocíclico substituído por halogênio, antagonista do receptor de lpa, composição farmacêutica e uso | |
BRPI1011657A2 (pt) | derivados aminopropiônicos substituídos como inibidores de neprilisina | |
BRPI0814231B8 (pt) | derivados de pleuromutilina, seu uso e composição farmacêutica | |
BR112012033770A2 (pt) | novo derivado de nicotinamida ou sal do mesmo | |
CO6251282A2 (es) | Oxazolidinonas sustituidas y su uso | |
BR112018011788A2 (pt) | formas sólidas de éster etílico de ácido (2r,4s)-5-(bifenil-4-il)-4-[(3-carboxipropionil)amino]-2-metil-pentanoico, seus sais e um método de preparação | |
NO20092224L (no) | Quiniklidinderivater av (hetero)arylcykloheptankarboksylsyre som muskarinreseptorantagonister | |
AR078278A1 (es) | Antagonistas de la tiazol y oxazol hepcidina, composiciones farmaceuticas que los contienen y uso de los mismos para el tratamiento de anemias y enfermedades asociadas a deficiencias de hierro. | |
AR074608A1 (es) | Derivados de 2-(piperidin-1-il)-4-heterociclil-tiazol-5-carboxilico para infecciones bacterianas | |
ECSP13012664A (es) | Formas cristalinas de la sal clorhidrato de (4a-r,9a-s)-1-(1h-benzoimidazol-5-carbonil-2,3,4,4a,9,9a-hexahidro-1h-inden[2,1-b]piridin-6-carbonitrilo y su uso como inhibidores de hsd 1 | |
NI200900181A (es) | Nuevos compuestos heterocíclicos nitrogenados, su preparación y su utilización como medicamentos antibacterianos. | |
BRPI0919812A8 (pt) | Combinações de compostos antibacterianos heterocíclicos hirdrogenados com outros compostos antibacterianos e o uso dos mesmos como medicamentos | |
CO2019004978A2 (es) | Compuestos terapéuticos y métodos para utilizarlos | |
BRPI0511999A (pt) | compostos como antagonistas de ccr5 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
B25A | Requested transfer of rights approved |
Owner name: ASTRA ZENECA HOLDING FRANCE S.A.S. (FR) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |